Key facts
- Notable investors include Green Pine Capital Partners, Haier Financial Holdings, Hongchuang Capital, Sunland Fund, Yushan Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for IMADEK
- ·The full record, as it builds
Funding rounds
No funding rounds for IMADEK are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IMADEK
Manufacturer of life-science automation systems intended for standardized laboratory and medical-device operational purposes. The company incorporates independently developed hardware modules, automated handling systems, data-integration functions, device-safety controls, standardized workflow mechanisms, multi-level quality-management processes, compatibility frameworks for laboratory environments, and support for research collaborations, enabling clinical, laboratory, and medical-equipment markets to improve operational consistency, enhance process safety, strengthen information traceability, and increase overall efficiency in life-science automation scenarios.
- Sector
- Healthcare
- HQ
- Changsha, China
- Founded
- 2016
- Employees
- 50
- Website
- csmadik.com/
- Ownership
- Privately Held (backing)
IMADEK doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IMADEK shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IMADEK in its N-PORT filings yet. We sweep new filings monthly.